Jelajahi eBook
Kategori
Jelajahi Buku audio
Kategori
Jelajahi Majalah
Kategori
Jelajahi Dokumen
Kategori
Actions
of
Methylripariochromene
from
20. Goligorsky MS, Gross SS. The ins and outs of endothelial dysfunction : much
a do about NO-thing. Drug New Perspect 2001; 14 : 133-42
21. Sargowo D. Peran endotel pada patogenesis penyakit kardiovaskular dan
program pencegahannya. Medika 1999; 10 : 643-55
22. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Effects of
antihypertensive drugs on endothelial dysfunction. Drugs 2002; 62 : 265-84
23. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med
1993; 329 : 2002-12
24. Guyton AC, Hall JE. Buku ajar fisiologi kedokteran. Chapter 67-69,71,74,78.
Edisi XI. Jakarta: EGC; 2007.
25. Ganong, W. F. 2003. Buku Ajar Fisiologi Kedokteran Ganong. Edisi 22,
Jakarta:EGC
26. Badan Penelitian Dan Pengembangan Kesehatan Kementerian Kesehatan RI.
Riset Kesehatan Dasar Riskesdas. 2013
27. World Health Organization, Global status report on noncommunicable disease
2010. Geneva, World Health Organization, 2011
28. What
is
high
blood
pressure?
American
Heart
Association.
http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/AboutHig
hBloodPressure/What-is-High-Blood-Pressure_UCM_301759_Article.jsp.
Accessed Dec. 13, 2013
29. Wade, A Hwheir, D N Cameron, A. 2003. Using a Problem Detection Study
(PDS) to Identify and Compare Health Care Privider and Consumer Views of
Antihypertensive therapy. Journal of Human Hypertension, Jun Vol 17 Issue
6, p397.
30. Anonim.Hipertensi.Primer.http://www.scribd.com/doc/3498615/HIPERTENSI
PRIMER?autodown=doc. Diakses pada tanggal 20 Juni 2014
K,
et
all.
Hypertension.
Last
update
May
11
2008.
Epidemiologi
Bagian
Epidemiologi
http;//www.CerminDunia
FKM
UNHAS.
2007.
Kedokteran.com/index.php?
D.
Apa
Manfaat
Garam
Sebagai
Bahan
Pengawat.
http://id.answers.yahoo.com/question/index;_ylt=Aj3eh2PdCnd0po.ZrHRTkN
LVRg x.;_ylv=3?qid=20080814042051AAWyOOk. Diakses pada tanggal 25
Juni 2014
37. Sianturi G. Cegah Hipertensi dengan Pola Makan. Last update 27 Februari
2003. www.gizi.net/cgi-bin/berita/fullnews.cgi?newsid1046314663,16713, 24k. Diakses pada tanggal 25 Juni 2014
38. Bowman ST et al. Clinical Research Hypertension. A Prospective Study of
Cigarette Smokey And Risk of Inciden Hypertension In Bringham And
Women Hospital
39. Sarwoyo HD dan Hendarwo M. Pola Perilaku Type A (PPTA) Pada Penyakit
Jantung Koroner (PJK). Fakultas Kedokteran Universitas Brawijaya, Malang.
http://www.tempo.co.id/medika/arsip/092002/art-2.htm.
Massachucetts,
2007.p 1-3.
40. World Health Organization, Global status report on noncommunicable disease
2010. Geneva, World Health Organization, 2011
41. Carretero OA, Oparil S. Essential hypertension : Part I :Definition and
etiology. Circulation 2000; 101: 329-35.
42. Lifton RP. Molecular genetics of human blood pressure variation. Science
1996; 276: 676-80.
43. Lifton RP. Genetic determinants of human hypertension.Proc Natl Acad Sci
USA 1995; 92: 8545-51.
44. Sanjay Vicraut, SC Tiwari. 2001. Essential Hypertension-Pathogenesis and
Pathophysiology. Journal, indian academy of clinical medicine. Vol2, No.3.
leading article.
45. Laragh JH. The renin system and four lines of hypertension research.
Hypertension 1992; 20: 267-79.
46. Swales JD. Functional disturbances of the cell membrane in hypertension. J
Hypertens 1990; 8 (Suppl 7): S203-S211.
47. Campese VM, Tawadrous M, Bigazzi R et al. Salt intake and plasma arterial
natriuretic peptide and nitric oxide in hypertension. Hypertension 1996; 28:
335-40.
48. Barba G, Cappuccio FP, Russ L et al. Renal function and blood pressure
response to dietary salt restriction in normotensive men. Hypertension 1996;
27: 1160-4.
49. Resnick LH, Gupta RK, Difabio B et al. Intercellular ionic consequences of
dietary salt loading in essential hypertension. J Clin Invest 1994; 94: 1269-74.
50. K. S. Meera, Sara Rani Marcus. Endothelial dysfunction and oxidative stress
in hypertension. Department of Biochemistry,M.S. Ramaiah Medical College,
MSR Nagar, Bangalore. India.2012; 1: 2277-7253
51. Stiffert W, Dusing R. Sodium proton exchange and primary hypertension.
Hypertension 1995; 26: 649-55
52. Compese VM, Mann A, Wuzgaft A. Effect of I-arginine on systemic and renal
hemodynamics in salt-sensitive hypertension [Abstract]. J Am Soc Neghool
1996; 7:1547.
53. Dierk H. Endemann, Ernesto L. Schiffrin. Endothelial Dysfunction. J Am Soc
Nephrol 15: 19831992, 2004
54. Miltenyi Biotec GmbH. Applications for the enrichment column of the
MACSQuant Analyzer Enumeration of circulating endothelial cells. CEC
Enrichment and Enumeration Kit: January 2012; 1-4.
55. Erdbruegger U, Haubitz M, Woywodt A. Review: Circulating endothelial
cells: A novel marker of endothelial damage. Department of Medicine,
Division of Nephrology, Hannover Medical School, Carl-Neuberg-Strasse 1,
D-30625 Hannover, Germany. Elsevier: U. Erdbruegger et al./Clinica Chimica
Acta 373: 2006; 1726.
56. Grosjean J, Kiriakidis S, Reilly K, Feldmann M, Paleolog E. Vascular
endothelial growth factor signalling in endothelial cell survival: a role for
NFkappaB. Biochem Biophys Res Commun 2006;340:98494.
57. Frontiers in Bioscience S1, 304-318, June 1, 2009
58. Michael H. Cardone, Guy S. Salvesen, Christian Widmann, Gary Johnson,
Steven M. Frisch. 1997. The Regulation of Anoikis: MEKK-1 Activation
Requires Cleavage by Caspases. Cell, vol 90, 315-323
59. Douglas D. Bannerman, Malathi Sathyamoorthy and Simeon E. Goldblum.
1998. Bacterial Lipopolysaccharide Disrupts Endothelial Monolayer Integrity
69. Silvia Duarte, Daniel Arango, Arti Parihar, Patrice Hamel, Rumana Yasmeen
and Andrea I. Doseff. 2013. Apigenin Protects Endothelial Cells from
Lipopolysaccharide (LPS)-Induced Inflammation by Decreasing Caspase-3
Activation and Modulating Mitochondrial Function. International Journal of
Molecular Sciences. 14, 17664-17679
70. Diakses
dari
http://www.globinmed.com/index.php?option=com_content&
vascular
smooth
muscle.
Mol
Pharmacol
65:851859,
2004.original article.
90. Manuel Sanchez, Milagros Galisteo.2006. Quercetin downregulates NADPH
oxidase, increase eNOS activity and prevents endothelial dysfunction in
spontaneously hypertensive rats. Journal of Hypertension, 24:7584.original
article.
91. Schut GA, Zwaving JH. Pharmacological investigation of some lipophilic
flavonoids from Orthosiphon aristattts . Fitoterapia 1993; 64 : 99-102
92. Efendi Jefri. Efek Ramuan Dekok Pegagan, Alang-Alang, Kumis Kucing
Terhadap Kadar Nitric Oxide Jaringan Arteri Ekor Tikus Model Hipertensi.
2014 in publishing.
93. Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids:
structureactivity relationships. Free Radic Biol Med 1997;22:74960.
94. Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry,
metabolism and structureactivity relationships. J Nutr Biochem 2002;13:
57284.
95. Hanasaki Y, Ogawa S, Fukui S. The correlation between active oxygens
scavenging and antioxidative effects of flavonoids. Free Radic Biol Med
1994;16:84550.
96. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. third ed.
Oxford: Oxford University Press; 1998.
97. Stadler N, Lindner RA, Davies MJ. Direct detection and quantification of
transition metal ions in human atherosclerotic plaques: evidence for the
presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol
2004;24:94954.
98. YenGC,Duh PD, TsaiHL,Huang SL. Pro-oxidative properties of flavonoids in
human lymphocytes. Biosci Biotechnol Biochem 2003;67:121522.
99. Bayrakeken F, Aktas S, Toptan M, Unlugedik A. High resolution electronic
absorption spectra of anisole and phenoxyl radical. Spectrochim Acta
2003;59:1358.
100.
generation of reactive
103.El Hajji H, Nkhili E, Tomao V, Dangles O. Interactions of quercetin with iron and
copper ions: complexation and autoxidation. Free Radic Res 2006;40:30320.
104.Toshiyuki Matsubara,Takako Bohgaki et al.Antihypertensive Action of
Methylripariochromene
from
Orthosiphon
aristatus,an
Indonesian